Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 17.89 million shares were traded. FOLD stock price reached its highest trading level at $14.22 during the session, while it also had its lowest trading level at $14.18.
Ratios:
Our analysis of FOLD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 453.59. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.88.
On December 17, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $17. Needham Upgraded its Hold to Buy on September 18, 2025, while the target price for the stock was maintained at $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’25 when Clark David Michael sold 25,642 shares for $14.17 per share. The transaction valued at 363,380 led to the insider holds 245,690 shares of the business.
DAVID CLARK bought 25,642 shares of FOLD for $279,241 on Dec 19 ’25. On Dec 15 ’25, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 77,926 shares for $10.86 each. As a result, the insider received 846,011 and left with 1,129,782 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 4395180544 and an Enterprise Value of 4563239936. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.34 while its Price-to-Book (P/B) ratio in mrq is 19.02. Its current Enterprise Value per Revenue stands at 7.622 whereas that against EBITDA is 108.339.
Stock Price History:
The Beta on a monthly basis for FOLD is 0.43, which has changed by 0.4544524 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, FOLD has reached a high of $14.36, while it has fallen to a 52-week low of $5.51. The 50-Day Moving Average of the stock is 46.79%, while the 200-Day Moving Average is calculated to be 83.95%.
Shares Statistics:
FOLD traded an average of 8.58M shares per day over the past three months and 27741380 shares per day over the past ten days. A total of 308.50M shares are outstanding, with a floating share count of 302.15M. Insiders hold about 2.07% of the company’s shares, while institutions hold 103.15% stake in the company. Shares short for FOLD as of 1764288000 were 19305562 with a Short Ratio of 2.25, compared to 1761868800 on 17047849. Therefore, it implies a Short% of Shares Outstanding of 19305562 and a Short% of Float of 6.3.
Earnings Estimates
The dynamic stock of Amicus Therapeutics Inc (FOLD) is currently attracting attention from 5.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.09, with high estimates of $0.14 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.44 and $0.32 for the fiscal current year, implying an average EPS of $0.38. EPS for the following year is $0.65, with 5.0 analysts recommending between $0.79 and $0.56.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 9 analysts. It ranges from a high estimate of $184.74M to a low estimate of $174.31M. As of. The current estimate, Amicus Therapeutics Inc’s year-ago sales were $149.71MFor the next quarter, 9 analysts are estimating revenue of $162.32M. There is a high estimate of $172.6M for the next quarter, whereas the lowest estimate is $148.55M.
A total of 10 analysts have provided revenue estimates for FOLD’s current fiscal year. The highest revenue estimate was $635.5M, while the lowest revenue estimate was $623.3M, resulting in an average revenue estimate of $629.23M. In the same quarter a year ago, actual revenue was $528.29MBased on 10 analysts’ estimates, the company’s revenue will be $745.12M in the next fiscal year. The high estimate is $756.2M and the low estimate is $733.19M.
